ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975

Study Begins On Link Between Down Syndrome, Leukemia

May 28, 2004

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002